Company intelligence / Profile preview

Jilin Qijian Bio-Pharmaceutical

Changchun, Jilin, China

Ownership: Private
Development stage: Other

Overview

Jilin Qijian Bio-Pharmaceutical is a Chinese biopharmaceutical company specializing in the research, development, and manufacturing of human vaccines. Based in Changchun, the company is best known for its production of the Rabies Vaccine (Human Diploid Cell), which is considered a high-standard treatment for rabies prevention due to its purity and low incidence of side effects. Additionally, the company produces vaccines for Hemorrhagic Fever with Renal Syndrome (HFRS). Jilin Qijian operates large-scale GMP-certified manufacturing facilities to supply the domestic Chinese market. Its focus remains on infectious disease prevention through advanced cell culture technologies.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Biotech

Beyond the preview

Go deeper on Jilin Qijian Bio-Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jilin Qijian Bio-Pharmaceutical.

Explore the full profile